Investig Clin Urol.  2021 Nov;62(6):631-640. 10.4111/icu.20210297.

Robotic-assisted versus open simple prostatectomy: Results from a systematic review and meta-analysis of comparative studies

Affiliations
  • 1Urology Unit, Azienda Ospedaliero-Universitaria “Ospedali Riuniti di Ancona”, Università Politecnica delle Marche, Ancona, Italy
  • 2Department of Urology, Ng Teng Fong General Hospital, NUHS, Jurong East, Singapore
  • 3S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China
  • 4Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
  • 5Department of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
  • 6ORSI Academy, Melle, Belgium
  • 7Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
  • 8Department of Urology, University of Modena and Reggio Emilia, Modena, Italy

Abstract

Purpose
To review safety and efficacy of robotic-assisted simple prostatectomy (RASP) compared to open simple prostatectomy (OP).
Materials and Methods
A comprehensive literature search was performed to assess the differences in perioperative course and functional outcomes in patients with benign prostatic hyperplasia and surgical indication. The incidences of complications were pooled using the Cochran–Mantel–Haenszel Method and expressed as odds ratio (OR), 95% confidence interval (CI), and p-values. Perioperative course and functional outcomes were pooled using the inverse variance of the mean difference (MD), 95% CI, and pvalues. Analyses were two-tailed and the significance was set at p<0.05.
Results
Eight studies were accepted. Meta-analysis showed significantly longer surgical time (MD, 43.72; 95% CI, 30.57–56.88; p<0.00001) with a significantly lower estimated blood loss (MD, -563.20; 95% CI, -739.95 to -386.46; p<0.00001) and shorter postoperative stay (MD, -2.85; 95% CI, -3.72 to -1.99; p<0.00001) in RASP. Catheterization time did not differ (MD, 0.65; 95% CI, -2.17 to 3.48; p=0.65). The risk of blood transfusion was significantly higher in OP (OR, 0.23; 95% CI, 0.17–0.33; p<0.00001). The risk of recatheterization (OR, 1.96; 95% CI, 0.32–11.93; p=0.47), postoperative urinary infections (OR, 0.89; 95% CI, 0.23–3.51; p=0.87) and 30-day readmission rate (OR, 0.96; 95% CI, 0.61–1.51; p=0.86) did not differ. At 3-month follow-up, functional outcomes were similar.
Conclusions
RASP demonstrated a better perioperative outcome and equal early functional outcomes as compared to OP. These findings should be balanced against the longer operative time and higher cost of robotic surgery.

Keyword

Patient outcome assessment; Postoperative complications; Prostatectomy; Prostatic hyperplasia; Robotic surgical procedures
Full Text Links
  • ICU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr